Wechat

Website

Chinese Journal of Oncology Prevention and Treatment ›› 2018, Vol. 10 ›› Issue (3): 209-212.doi: 10.3969/j.issn.1674-5671.2018.03.09

Previous Articles     Next Articles

Expression of nuclear factor erythroid-2-related factor 2 in peripheral T-cell lymphoma and its clinical significance

  

  • Online:2018-06-25 Published:2018-07-02

Abstract:

Objective To investigate the expression and its clinical significance of nuclear factor erythroid-2-related factor 2(Nrf2) in peripheral T-cell lymphoma(PTCL). Methods  Expression of Nrf2 was detected by immunohistochemistry in 24 patients with PTCL and 17 patients with reactive hyperplasia of lymph nodes,and associations between expression level and clinico-pathological features were analyzed. All data were analyzed using SPSS 23.0 software. Results The positive rate of Nrf2 expression was significantly higher in PTCL (41.67%) than in reactive hyperplasia of lymph node tissues (5.88%,P<0.05). Expression of Nrf2 was related to Ann-Arbor clinical stage and B symptom(P<0.05),while it was unrelated to patient age,gender or LDH(P>0.05). Conclusions The increased expression of Nrf2 in PTCL suggests that Nrf2 may play an important role in the development of PTCL.

Key words: Peripheral T-cell lymphoma, Nuclear factor erythroid-2-related factor 2, Immunohistochemistry, Clinical significance